John Harris

CEO, OBN

John brings to OBN extensive leadership and managerial competence developed within well respected Blue-Chip, Governmental and SME organisations, specialised in the Life Sciences Sectors. Over his 36 years working in this space (including 22 years at CEO level), he has developed considerable experience and expertise within the Biotech, pharmaceutical and medical technology arenas ranging through research, technical & commercial development, registration, manufacture, marketing, and sales.

Immediately prior to joining OBN he was Managing Partner of LifeAgility Associates, a specialist consultancy focused on strategy and business support for Life Sciences SME's and also provided expert participation in the development of the UKTI Government Life-Sciences 10-year strategy plan.

Previous appointments include Managing Director of IPS Specials (a cGMP, MHRA licensed manufacturer of pharmaceuticals), Managing Director of Key Organics Ltd (a leading manufacturer of chemical intermediates), Managing Director of Synerga Ltd (a start-up drug discovery venture), Chairman & CEO of TraceTag International Ltd (a biotech company specialising in hi-tech diagnostics), Managing Director of AgriSense-BCS (specialist biorationals manufacturer), and senior management roles in Zeneca, Novo Nordisk (Denmark), Monsanto (Belgium), and Shell.

John received the HSBC / SVBA Business Leader of the Year 2019 Award.

He holds a BSc (Hons) in Biology from the University of Salford, a PhD in Biochemistry from the University of Southampton and an MBA from the University of Surrey.